comparemela.com

Latest Breaking News On - கிளின்ட் கூர்மையானவை - Page 5 : comparemela.com

NA Proactive news snapshot: The Good Shroom Co Inc, Golden Minerals Company, Codebase Ventures Inc, Vicinity Motor Corp …

NA Proactive news snapshot: The Good Shroom Co, Golden Minerals, Codebase Ventures, Vicinity Motor … A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive The Good Shroom Co Inc. (CVE:MUSH), previously Cluny Capital Corp, (CVE:CLN.H), a Toronto Venture Exchange (TSX) capital pool company, has announced the completion of its qualifying transaction, which involved the amalgamation of Teonan Biomedical Inc. with the company s wholly-owned subsidiary, as part of a three-cornered amalgamation between the parties. Immediately prior to the transaction, the company was continued under the Canada Business Corporations Act, its outstanding common shares were consolidated on a 3 for 1 basis and, the company changed its name to The Good Shroom Co Inc. (Les Bons Champignons Inc.).

NA Proactive news snapshot: Todos Medical Ltd, Kainantu Resources Ltd, CleanSpark Inc, Arcadia Biosciences Inc UPDATE …

NA Proactive news snapshot: Todos Medical, Kainantu Resources, CleanSpark, Arcadia Biosciences UPDATE … A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Todos Medical Ltd (OTCQB:TOMDF) has announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 clinical trial of antiviral Tollovir for the treatment of hospitalized coronavirus (COVID-19) patients. The trial is being conducted at Shaare Zedek Medical Center in Jerusalem, Israel, and will evaluate the safety and efficacy of Tollovir, the company said. Tollovir is a patent-pending therapeutic agent being developed through a joint venture between Todos and NLC Pharma. It is among 3CL protease inhibitors that are targeted as desirable candidates for the development of antiviral therapies against SARS-CoV-2, the virus that causes the COVID-19 disease.

Heritage Cannabis Set to Initiate U S Product Launch Through Relationship With Merida Capital Holdi

Search jobs Heritage Cannabis Set to Initiate U.S. Product Launch Through Relationship With Merida Capital Holdings Strategic relationship with Merida Capital Holdings to assist Heritage with expanding product distribution in strategic states and with further opportunities to accelerate U.S. presence TORONTO (BUSINESS WIRE) Heritage Cannabis Holdings Corp. (CSE:CANN) (OTCQX:HERTF) (“Heritage” or the “Company”), today announced that it has expanded its relationship with Merida Capital Holdings (“Merida”) to leverage Merida’s strategic portfolio of companies in the sector and rapidly advance the Company’s U.S. product distribution strategy. Upon closing of the Premium 5 acquisition in January 2021, Merida, the largest non-insider investor in Premium 5 became a strategic shareholder in Heritage. The agreement will see the two companies partnering to strategically expand Heritage’s product distribution in the U.S. This relationship will see

Heritage Cannabis expands agreement with Merida that includes U S Distribution

Heritage Cannabis expands agreement with Merida that includes U.S. Distribution Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has expanded its relationship with Merida Capital Holdings. Merida, the largest non-insider investor in Premium 5, became a strategic shareholder in Heritage back in January of 2021. Sharples telling Proactive this expanded agreement will give Heritage distribution into the U.S. with the focus to start initially in Michigan, Missouri, West Virginia and California. Quick facts: Heritage Cannabis Holdings Corp. Price: 0.135 CAD

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.